You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Non-small cell

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Double-dose Furmonertinib in Treatment of Slow

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • (no location specified)
Oct 31, 2023

NSCLC, EGFR Gene Mutation, EGFR-TKI Resistant Mutation Trial (Nintedanib, gefitinib, erlotinib, afatinib)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • Nintedanib, gefitinib, erlotinib, afatinib
  • (no location specified)
Oct 2, 2023

Stage II-IIIB(N2) NSCLC Trial in Shanghai (TQB2450, Carboplatin, Pemetrexed)

Not yet recruiting
  • Stage II-IIIB(N2) Non-small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Oct 26, 2023

Specific Protein Overexpression in Adult Non-Small Cell Lung

Not yet recruiting
  • Non Small Cell Lung Cancer
    • (no location specified)
    Sep 29, 2023

    NSCLC, Neoadjuvant Therapy, Radiotherapy Trial in Yangzhou (drug, radiation, other)

    Recruiting
    • Non-small Cell Lung Cancer
    • +3 more
    • Yangzhou, Jiangsu, China
      People's hospital of northern jiangsu
    Sep 26, 2023

    NSCLC Trial in Shanghai

    Not yet recruiting
    • Non-small Cell Lung Cancer
      • Shanghai, Shanghai, China
        Shanghai Pulmonary Hospital
      Jul 20, 2023

      NSCLC Trial (Tirelizumab;Chemotherapy monotherapy)

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • Tirelizumab；Chemotherapy monotherapy
      • (no location specified)
      Jul 27, 2023

      NSCLC Trial in Iowa City (Durvalumab, Pharmacological ascorbate, Surgery (SOC))

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • Iowa City, Iowa
        University of Iowa
      Oct 10, 2023

      Stage IB Non-small Cell Lung Cancer

      Completed
      • Stage IB Non-Small Cell Lung Carcinoma
        • Shanghai, China
          180 Fenglin Road
        Jul 29, 2023

        Non Small Cell Lung Cancer Metastatic Trial (MRI)

        Not yet recruiting
        • Non Small Cell Lung Cancer Metastatic
        • MRI
        • (no location specified)
        May 16, 2023

        NSCLC With Mutation in Epidermal Growth Factor Receptor Trial (Osimertinib, Aspirin)

        Not yet recruiting
        • Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
        • (no location specified)
        Aug 27, 2023

        NSCLC Trial in Wuhan (Cadonilimab, Pemetrexed, Carboplatin)

        Recruiting
        • Carcinoma, Non-Small-Cell Lung
        • Wuhan, Hubei, China
          Qian Chu
        Aug 18, 2023

        NSCLC Trial in Beijing

        Recruiting
        • NSCLC
          • Beijing, China
            Yuyan Wang
          Oct 10, 2023

          Identify Resected Non-small-cell Lung Cancer With High Risk of

          Recruiting
          • Non-small Cell Lung Cancer Stage IIIA
          • Resected non small cell lung cancer
          • Toulouse, France
            Julien MAZIERES
          Feb 8, 2023

          NSCLC Trial (BGB-A445, Docetaxel, Tislelizumab)

          Not yet recruiting
          • Non-Small Cell Lung Cancer
          • (no location specified)
          Sep 6, 2023

          Iruplinalkib in Treatment of ALK-Positive Non-Small Cell Lung

          Recruiting
          • Non-small Cell Lung Cancer (NSCLC)
          • Jinan, Shandong, China
            Shandong Cancer Hospital and Institute
          Aug 8, 2023

          NSCLC Trial (SGN-B6A, docetaxel)

          Not yet recruiting
          • Carcinoma, Non-Small-Cell Lung
          • (no location specified)
          Aug 21, 2023

          Learn About Dacomitnib in Non-small Cell Lung Cancer Which Has

          Not yet recruiting
          • Carcinoma, Non-Small-Cell Lung
          • (no location specified)
          Oct 4, 2023

          NSCLC Trial in Omaha (PLB1004)

          Not yet recruiting
          • Non-Small Cell Lung Cancer
          • Omaha, Nebraska
            Nebraska Cancer Specialists
          Sep 19, 2023

          Untreated Advanced NSCLC Trial in Fuzhou (Recombinant human adenovirus type 5 injection (H101) combined with tirilizumab and

          Recruiting
          • Untreated Advanced Non-small Cell Lung Cancer
          • Recombinant human adenovirus type 5 injection (H101) combined with tirilizumab and platinum-containing two-drug chemotherapy
          • Fuzhou, Fujian, China
            Fujian Cancer Hospital
          Nov 13, 2023

          Advanced NSCLC Trial in Jinan (almonertinib)

          Recruiting
          • Advanced Non-small Cell Lung Cancer
          • Jinan, Shandong, China
            Degan Lu
          Sep 12, 2023

          NSCLC Trial (Tislelizumab IV, Tislelizumab SC, Histology-Based Chemotherapy Doublet)

          Not yet recruiting
          • Non-small Cell Lung Cancer
          • Tislelizumab IV
          • +2 more
          • (no location specified)
          Oct 25, 2023

          Examination of Trends in Non-Small Cell Lung Cancer Patients'

          Not yet recruiting
          • Non-Small Cell Lung Cancer
            • (no location specified)
            Mar 10, 2023

            NSCLC Trial in Guangzhou (BL-M07D1)

            Not yet recruiting
            • Non-small Cell Lung Cancer
            • Guangzhou, Guangdong, China
              Sun Yat-sen University Cancer Center
            Nov 1, 2023

            Non Small Cell Lung Cancer, Propranolol Trial (Propranolol HCl, Sintilimab, Chemotherapy)

            Not yet recruiting
            • Non Small Cell Lung Cancer
            • Propranolol
            • Propranolol hydrochloride
            • +2 more
            • (no location specified)
            Jul 31, 2023